Research at Wilmer: Targeted Dye Delivery to Manage Macular Degeneration

• A New Building for the Wilmer Eye Institute (view video)
• Parking Changes at the Johns Hopkins Hospital
• Wilmer Laser Vision Center
• Clinician-Scientist Training Program
• Support Wilmer using the new Online Giving Form

Julia Haller, professor of ophthalmology at Johns Hopkins explains why controversy swirls around Lucentis, a new drug approved by the FDA for the treatment of macular degeneration.

• Podcast (8.3MB)
• Powerpoint Podcast